PCM
NVLN

Prelude Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Prelude Capital Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,600
Closed -$24K – 1903
2017
Q2 		$24K Sell
2,600
-15,491
-86% -$143K ﹤0.01% 1111
2017
Q1 		$194K Sell
18,091
-6,585
-27% -$70.6K 0.02% 530
2016
Q4 		$208K Buy
+24,676
New +$208K 0.03% 534